Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000092

CEO bought 27,637 shares at an average $0.13 ($3,545)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-24 Purchase : show line 1 in the form +3,000 $0.13 $375 7,183,342 D
2016-08-25 Purchase : show line 2 in the form +14,637 $0.12 $1,815 7,197,979 D
2016-08-25 Purchase : show line 3 in the form +5,000 $0.13 $655 7,202,979 D
2016-08-25 Purchase : show line 4 in the form +5,000 $0.14 $700 7,207,979 D
Open-market purchases · 27,637 sh · avg $0.13 · $3,545
Loading xslF345X03/primary_doc.xml…